Similar companies
Did CytoSorbents Beat Earnings?
CytoSorbents (CTSO) reported Q2 '26 revenue of $9.6M, up 0.2% year-over-year.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — CytoSorbents’s job postings, web traffic, and employee business outlook. See the full CTSO stock analysis or the earnings calendar for upcoming reports.
CytoSorbents Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.6M | 9.2M | 8.7M | 9.6M | 9.5M | 9.2M | 8.9M | 9.6M |
| Gross margin | 52.3% | 102.7% | 71.1% | 70.9% | 70.3% | 73.7% | 69.2% | 73.2% |
| Operating margin | -51.0% | -44.2% | -44.5% | -37.6% | -30.2% | -42.0% | -34.3% | -27.4% |
| Net income | -2.3M | -7.9M | -1.5M | 1.9M | -3.2M | -5.5M | -5.1M | -4.4M |
| Net margin | -27.1% | -86.2% | -16.9% | 20.2% | -33.4% | -59.5% | -57.9% | -45.9% |
| EPS | — | — | — | — | — | — | — | — |
CytoSorbents Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, CytoSorbents’s quarterly revenue moved from $8.6M to $9.6M. Net margin compressed from -27.1% to -45.9%, against a 73.2% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit.
When Is CytoSorbents’s Next Earnings Date?
CytoSorbents reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the CTSO earnings calendar.
Frequently Asked Questions: CytoSorbents Earnings
CytoSorbents's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
CytoSorbents reported Q2 '26 revenue of $9.6M, up 0.2% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the CTSO AI Score.
